Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Income from Non-Controlling Interests (2017 - 2025)

Historic Income from Non-Controlling Interests for BioCorRx (BICX) over the last 7 years, with Q3 2025 value amounting to -$1.1 million.

  • BioCorRx's Income from Non-Controlling Interests fell 442959.06% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 5259.81%. This contributed to the annual value of -$5.3 million for FY2021, which is 5201.7% down from last year.
  • BioCorRx's Income from Non-Controlling Interests amounted to -$1.1 million in Q3 2025, which was down 442959.06% from -$143858.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Income from Non-Controlling Interests registered a high of $25623.0 during Q3 2024, and its lowest value of -$1.6 million during Q1 2021.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was -$1.1 million (2021), whereas its average is -$815329.6.
  • In the last 5 years, BioCorRx's Income from Non-Controlling Interests plummeted by 4082.46% in 2021 and then tumbled by 442959.06% in 2025.
  • Quarter analysis of 3 years shows BioCorRx's Income from Non-Controlling Interests stood at -$1.3 million in 2021, then skyrocketed by 102.02% to $25623.0 in 2024, then tumbled by 4429.59% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, -$143858.0 for Q2 2025, and $25623.0 during Q3 2024.